Clinical Trials Sponsored by Moe Medical Devices

Total 1223 results

Abbott Medical Devices

Completed

Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients

Heart Failure

United States
Abbott Medical Devices

Completed

Efficacy and Safety Study on Agilis NxT Introducer in AF Patients (AGILIS)

Atrial Fibrillation

Germany
Abbott Medical Devices

Completed

Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment

Bradycardia

Austria
Abbott Medical Devices

Withdrawn

Placement of CS/LV Pacing Leads With EnSite NavX Guidance

Heart Failure

United States
Abbott Medical Devices

Completed

Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients (DECREASE)

Cardiac Death

Germany
Abbott Medical Devices

Completed

A Post Market Study to Assess the Spinal Modulation Neurostimulator System for Chronic Intractable Pain

Chronic Pain

Netherlands
Abbott Medical Devices

Terminated

PRIMA PFO Migraine Trial (PRIMA)

Migraine | Patent Foramen Ovale | Migraine With Aura | PFO

United Kingdom, Germany, Canada, Switzerland
Abbott Medical Devices

Withdrawn

Remote Interrogation in Rural Emergency Departments (REM RED)

Heart Failure | Cardiovascular Disease | Arrhythmias, Cardiac | Heart Disease

United States
Abbott Medical Devices

Completed

Clinical Evaluation Of Remote Monitoring With Direct Alerts To Reduce Time From Event To Clinical Decision (REACT)

The Patient Meets ACC/AHA/ESC Guidelines for Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy (CRT-D) Device

United Kingdom, Germany
Abbott Medical Devices

Completed

Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in Cardiac Resynchronisation Therapy (CRT) Patients (Efface)

Heart Failure

Germany
Abbott Medical Devices

Completed

Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation (PAFOS)

Atrial Fibrillation | Bradycardia

Germany
Abbott Medical Devices

Completed

Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Technique (INTREPID)

Heart Failure

Italy
Abbott Medical Devices

Completed

MultiPoint Pacing IDE Study (MPP IDE)

Heart Failure

United States
Abbott Medical Devices

Completed

Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices (zWedge)

Heart Failure

United States
Abbott Medical Devices

Completed

50/50% Tilt and Tuned Defibrillation Waveform

DFT Testing
Abbott Medical Devices

Completed

AnalyST Treadmill Study

Ischemic Heart Disease

Germany
Abbott Medical Devices

Withdrawn

Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients With St. Jude Medical (SJM) Implantable Cardioverter Defibrillator (ICD) Systems or Cardiac Resynchronization Therapy Defibrillation (CRT-D) Systems. (EPIC)

Monomorphic Ventricular Tachycardia
Abbott Medical Devices

Completed

Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention Indication (PROVIDE)

Shock

United States
Abbott Medical Devices

Completed

Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing Indication (TendrilMRI™)

Bradycardia
Abbott Medical Devices

Completed

Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant (SDD for ICD)

Coronary Artery Disease | Heart Failure

United States
Abbott Medical Devices

Completed

Characterization of Cardiac Hemodynamics During MultiSite Pacing

Heart Failure

Italy
Abbott Medical Devices

Completed

Septal Positioning of Ventricular Implanted Cardioverter Defibrillator (ICD) Leads (SPICE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Greece
Abbott Medical Devices

Terminated

MediGuide Registry

Heart Failure | Cardiac Arrhythmia

United States, Spain, Germany, Netherlands, Estonia, Canada, Austria, Australia
Abbott Medical Devices

Completed

EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension

Uncontrolled Hypertension

Germany
Abbott Medical Devices

Withdrawn

Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure (TAME-HF)

Heart Failure

France
Abbott Medical Devices

Completed

SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE)

Atrial Fibrillation

Hong Kong
Abbott Medical Devices

Withdrawn

A Post Market Study on DRG Stimulation in FBSS (SYMPATHY)

Failed Back Surgery Syndrome

Switzerland
Abbott Medical Devices

Terminated

BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement

Heart Failure

United States
Abbott Medical Devices

Completed

An Observational, Prospective Evaluation of the Trifecta™ Valve

Aortic Valve Stenosis | Aortic Valve Insufficiency | Regurgitation, Aortic Valve | Aortic Valve Incompetence

Germany, Netherlands, France
Abbott Medical Devices

Completed

Right Ventricular Outflow Tract Study (RVOTCARE)

Sinus-node Dysfunction

China
Abbott Medical Devices

Completed

Long Term Follow-up of the 23mm Portico™ Aortic Valve Implant and the St. Jude Medical Transfemoral Delivery System

Aortic Valve Stenosis

Canada
Abbott Medical Devices

Completed

CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements (CONFIRM)

Pacemaker

Canada
Abbott Medical Devices

Completed

EnSite™ HD Grid Catheter AF/AT Mapping Study

Non-paroxysmal Atrial Fibrillation | Left Atrial Tachycardia

Hong Kong, Australia, Italy, Germany, France
Abbott Medical Devices

Completed

QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization (QuickOpt)

Heart Failure

China
Abbott Medical Devices

Completed

STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial

Atrial Fibrillation

Spain, Canada, Italy, Norway
Abbott Medical Devices

Completed

EVEREST II Pivotal Study High Risk Registry (HRR) (HRR)

Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency

United States
Abbott Medical Devices

Completed

Pivotal Study of a Percutaneous Mitral Valve Repair System (EVERESTIIRCT)

Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Regurgitation | Mitral Valve Incompetence | Mitral Insufficiency

United States
Abbott Medical Devices

Completed

EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO)

Coronary Artery Disease (CAD) | Chronic Total Occlusion (CTO)

United States
Abbott Medical Devices

Completed

ABSORB EXTEND Clinical Investigation (ABSORB EXTEND)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Netherlands, Taiwan, China, New Zealand, Singapore, France, United Kingdom, Austria, Israel, Italy, Malaysia, India, Poland, Sweden, Spain, South Africa, Canada, Australia, Japan, Argentina, Brazil, Switzerland, Belgium, Denmark, Germany
Abbott Medical Devices

Completed

Absolute Pro® MOMENTUM™ (MOMENTUM)

Peripheral Vascular Disease | Peripheral Artery Disease

United States
Abbott Medical Devices

Unknown

A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression

Depressive Disorder | Treatment Resistant Depression

Canada
Abbott Medical Devices

Completed

A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain (PREDICT)

Chronic Pain

United Kingdom
Abbott Medical Devices

Completed

ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.

Coronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery Restenosis

Belgium
Abbott Medical Devices

Completed

Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy (CANOPY)

Stroke | Carotid Artery Disease | Amaurosis Fugax | Transient Ischemic Attack (TIA)

United States
Abbott Medical Devices

Completed

Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery (MOBILITY OE)

Peripheral Vascular Disease

United States
Abbott Medical Devices

Completed

Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. (MOBILITY AP)

Peripheral Vascular Disease

United States
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

SPIRIT PRIME Clinical Trial (SPIRIT PRIME)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Coronary Restenosis | Coronary Artery Stenosis

United States, Australia
Abbott Medical Devices

Completed

European Deep Brain Stimulation (DBS) Depression Study

Depressive Disorder, Major

Israel, France, United Kingdom
Abbott Medical Devices

Completed

CHOICE: Carotid Stenting For High Surgical-Risk Patients

Carotid Artery Disease

United States

Clinical Trials Sponsored by Moe Medical Devices

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations